Chain-Shattering Polymeric Therapeutics with On-Demand Drug-Release Capability

被引:131
作者
Zhang, Yanfeng [1 ]
Yin, Qian [1 ]
Yin, Lichen [1 ]
Ma, Liang [1 ]
Tang, Li [1 ]
Cheng, Jianjun [1 ]
机构
[1] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA
基金
美国国家科学基金会;
关键词
cancer therapy; controlled release; polymer-drug conjugate; polymers; trigger-responsive polymer; RING-OPENING POLYMERIZATION; HPMA COPOLYMER; CONJUGATE NANOPARTICLES; DOXORUBICIN CONJUGATE; CANCER-CELLS; DELIVERY; ANTICANCER; NANOMEDICINES; CAMPTOTHECIN; FORMULATION;
D O I
10.1002/anie.201300497
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Trigger happy: Trigger-responsive chain-shattering polymeric therapeutics (CSPTs) were prepared by condensation polymerization of a UV- or hydrogen peroxide-responsive domain and a drug as co-monomers. Drug release can be started and stopped by starting and stopping the trigger treatment. Chemotherapeutic-containing CSPTs showed trigger-responsive in vitro and in vivo antitumor efficacy. Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
引用
收藏
页码:6435 / 6439
页数:5
相关论文
共 56 条
[11]   Polymer-bound camptothecin: initial biodistribution and antitumour activity studies [J].
Caiolfa, VR ;
Zamai, M ;
Fiorino, A ;
Frigerio, E ;
Pellizzoni, C ;
d'Argy, R ;
Ghiglieri, A ;
Castelli, MG ;
Farao, M ;
Pesenti, E ;
Gigli, M ;
Angelucci, F ;
Suarato, A .
JOURNAL OF CONTROLLED RELEASE, 2000, 65 (1-2) :105-119
[12]   Polymer-drug conjugates as nano-sized medicines [J].
Canal, Fabiana ;
Sanchis, Joaquin ;
Vicent, Maria J. .
CURRENT OPINION IN BIOTECHNOLOGY, 2011, 22 (06) :894-900
[13]   Design strategies to improve soluble macromolecular delivery constructs [J].
Christie, RJ ;
Grainger, DW .
ADVANCED DRUG DELIVERY REVIEWS, 2003, 55 (03) :421-437
[14]   New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting [J].
Chytil, P. ;
Etrych, T. ;
Konak, C. ;
Sirova, M. ;
Mrkvan, T. ;
Boucek, J. ;
Rihova, B. ;
Ulbrich, K. .
JOURNAL OF CONTROLLED RELEASE, 2008, 127 (02) :121-130
[15]   Polymer conjugates as anticancer nanomedicines [J].
Duncan, Ruth .
NATURE REVIEWS CANCER, 2006, 6 (09) :688-701
[16]   Polymer therapeutics as nanomedicines: new perspectives [J].
Duncan, Ruth .
CURRENT OPINION IN BIOTECHNOLOGY, 2011, 22 (04) :492-501
[17]   Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities [J].
Duncan, Ruth ;
Vicent, Maria J. .
ADVANCED DRUG DELIVERY REVIEWS, 2010, 62 (02) :272-282
[18]   Synthesis and degradation characteristics of salicylic acid-derived poly(anhydride-esters) [J].
Erdmann, L ;
Uhrich, KE .
BIOMATERIALS, 2000, 21 (19) :1941-1946
[19]   Enhanced cytotoxicity of a polymer-drug conjugate with triple payload of paclitaxel [J].
Erez, Rotem ;
Segal, Ehud ;
Miller, Keren ;
Satchi-Fainaro, Ronit ;
Shabat, Doron .
BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (13) :4327-4335
[20]   Soluble Polymer Carriers for the Treatment of Cancer: The Importance of Molecular Architecture [J].
Fox, Megan E. ;
Szoka, Francis C. ;
Frechet, Jean M. J. .
ACCOUNTS OF CHEMICAL RESEARCH, 2009, 42 (08) :1141-1151